| Literature DB >> 22339096 |
Stefano Palomba1, Angela Falbo, Annalisa Di Cello, Caterina Materazzo, Fulvio Zullo.
Abstract
Nexplanon(®) is a new long-term reversible contraception method. The current review is aimed to analyze the published data concerning the contraceptive effectiveness of Nexplanon(®) and its effects on reproductive function. Pharmacological properties and technical procedures of insertion and removal, as well as the efficacy and safety data available, were discussed. Possible strategies for treating Nexplanon(®)-related bleeding were also described. With regard to the future research and the future scientific developments of contraceptive implants, the possible use of Nexplanon(®) wide-ranging for the symptomatic treatment of endometriosis and premenstrual syndrome (PMS) were considered. Finally, it was defined in which women the use of Nexplanon(®) is indicated and in which it is contra-indicated.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22339096 DOI: 10.3109/09513590.2011.652247
Source DB: PubMed Journal: Gynecol Endocrinol ISSN: 0951-3590 Impact factor: 2.260